Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

tive immune response. Curr Opin Immunol
1997; 9: 4±9.
42 Aderem, A. and Ulevitch, R. J. Tolllike
receptors in the induction of the innate
immune response. Nature 2000;
406: 782±787.
43 Medzhitov, R. and Janeway, C. The
toll receptor family and microbial recognition.
Trends Microbiol 2000; 8:
452±456.
44 Yamamoto,T.,Yamamoto, S., Kataoka,T.
and Tokunaga,T. Lipofection of synthetic
oligodeoxyribonucleotide having a
palindromic sequence of AACGTT to
murine splenocytes enhances interferon
production and natural killer activity. Microbiol
Immunol 1994; 38: 831±836.
45 Hacker, H., Mischak, H., Miethke, T.,
et al. CpG-DNA-specific activation of
antigen-presenting cells requires stress
kinase activity and is preceded by nonspecific
endocytosis and endosomal
maturation. EMBO J 1998; 17: 6230±
6240.
46 Manzel, L. and Macfarlane, D. E.
Lack of immune stimulation by immobilized
CpG-oligodeoxynucleotide. Antisense
Nucleic Acid Drug Dev 1999; 9:
459±464.
47 Mui, B., Raney, S. G., Semple, S. C.
and Hope, M. J. Immune stimulation
by a CpG-containing oligodeoxynucleotide
is enhanced when encapsulated
and delivered in lipid particles. J Pharmacol
Exp Ther 2001; 298: 1185±1192.
48 Macfarlane, D. E. and Manzel, L.
Antagonism of immunostimulatory
CpG-oligodeoxynucleotides by quinacrine,
chloroquine, and structurally related
compounds. J Immunol 1998; 160:
1122±1131.
49 Yi, A. K.,Tuetken, R., Redford,T., et al.
CpG motifs in bacterial DNA activate
leukocytes through the pH-dependent
generation of reactive oxygen species.
J Immunol 1998; 160: 4755±4761.
50 Hemmi, H., Takeuchi, O., Kawai, T.,
et al. A Toll-like receptor recognizes bacterial
DNA [In process citation]. Nature
2000; 408: 740±745.
51 Bauer, S., Kirschning, C. J.,
Hacker, H., et al. Human TLR9confers
responsiveness to bacterial DNA via
species-specific CpG motif recognition.
References
Proc Natl Acad Sci USA 2001; 98: 9237±
9242.
52 Krug, A., Towarowski, A., Britsch, S.,
et al. Toll-like receptor expression reveals
CpG DNA as a unique microbial
stimulus for plasmacytoid dendritic
cells which synergizes with CD40 ligand
to induce high amounts of IL-12.
Eur J Immunol 2001;
53 Stacey, K. J., Sweet, M. J. and
Hume, D. A. Macrophages ingest and
are activated by bacterial DNA. J Immunol
1996; 157: 2116±2122.
54 Hacker, H., Mischak, H., Hacker, G.,
et al. Cell type-specific activation of mitogen-activated
protein kinases by CpG-
DNA controls interleukin-12 release
from antigen-presenting cells. EMBO J
1999; 18: 6973±6982.
55 Yi, A. K. and Krieg, A. M. Rapid induction
of mitogen-activated protein kinases
by immune stimulatory CpG
DNA. J Immunol 1998; 161: 4493±4497.
56 Jakob, T.,Walker, P. S., Krieg, A. M.,
Udey, M. C. and Vogel, J. C. Activation
of cutaneous dendritic cells by CpGcontaining
oligodeoxynucleotides: a role
for dendritic cells in the augmentation
of T h1 responses by immunostimulatory
DNA. J Immunol 1998; 161: 3042±
3049.
57 Cowdery, J. S., Boerth, N. J.,
Norian, L. A., Myung, P. S. and
Koretzky, G. A. Differential regulation
of the IL-12 p40 promoter and of p40
secretion by CpG DNA and lipopolysaccharide.
J Immunol 1999; 162: 6770±
6775.
58 Hartmann, G. and Krieg, A. M. CpG
DNA and LPS induce distinct patterns
of activation in human monocytes.
Gene Ther 1999; 6: 893±903.
59 Sweet, M. J., Stacey, K. J., Kakuda, D. K.,
Markovich, D. and Hume, D. A. IFN-g
primes macrophage responses to bacterial
DNA. J Interferon Cytokine Res 1998;
18: 263±271.
60 Gao, J. J., Zuvanich, E. G., Xue, Q.,
et al. Cutting edge: bacterial DNA and
LPS act in synergy in inducing nitric
oxide production in RAW 264.7 macrophages.
J Immunol 1999; 163: 4095±
4099.
281